Angiogenesis in bladder cancer: Relationship between microvessel density and tumor prognosis

Journal of the National Cancer Institute

Volumn 87, Issue 21, 1995, Pages 1603-1612

  Bochner, Bernard H ^a   Cote, Richard J ^a   Weidner, Noel ^b   Groshen, Susan ^a   Chen, Su Chiu ^a   Skinner, Donald G ^a   Nichols, Peter W ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); PATIENT SELECTION; PROGNOSIS; TRANSITIONAL CELL CARCINOMA; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BLADDER NEOPLASMS; CARCINOMA, TRANSITIONAL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0028884557     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/87.21.1603     Document Type: Article

References (52)

1. Wingo PA, Tong T, Bolden S, Cancer statistics, 1995 [published erratum appears in CA Cancer J Clin 1995;45:127-85.
2. Skinner DG, Lieskovsky G., Management of invasive and high-grade bladder cancer. In: Skinner DG, Lieskovsky G, editors. Diagnosis and management of genitourinary cancer. Philadelphia: Saunders. 1988:295-312.
3. See WA, Fuller JR., Staging of advanced bladder cancer. Current concepts and pitfalls. Urol Clin North Am 1992;19:663-83.
4. Esrig D, Elmajian D, Groshen S, Freeman J, Stein JP, Chen SC, et al. Accumulation of nuclear p53 and tumor progression in bladder cancer [see comment citations in Medline]. N Engl J Med 1994:331:1259-64.
5. Folkman J, Cole P, Zimmerman S. Tumor behavior in isolated perfused organs: in vitro growth and métastasés of biopsy material in rabbit thyroid and canine intestinal segment. Ann Surg 1966;164:491-502.
6. Sutherland RM, McCredie JA, Inch WR. Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. J Natl Cancer Inst1971;46:113-20.
7. Gimbrone MA Jr, Leapman SB, Cotran RS, Folkman J. Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 1972;136:261-76.
8. Gimbrone MA Jr., Cotran RS, Leapman SB, Folkman J., Tumor growth neovascularization: an experimental model using rabbit cornea. J Natl Cancer Inst 1974;52:413-7.
9. Blood CH, Zetter BR. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1990; 1032:89-118.
10. Polverini PJ, Leibovich SJ. Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest 1984;51:635-42.
11. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987;235:442-7.
12. Srivastava A, Laidler P, Hughes LE, Woodcock J, Shedden EJ. Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study. Eur J Cancer Clin Oncol 1986;22:1205-9.
13. Srivastava A, Laidler P, Davies R, Horgan K, Huges LE. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. Am J Pathol 1988;133:419-23.
14. Barnhill RL, Fandrey K, Levy MA, Mihm MC Jr., Hyman B. Angiogenesis and tumor progression of melanoma. Quantitation of vascularity in melanocytic nevi and cutaneous melanoma. Lab Invest 1992;67:331-7.
15. Barnhill RL, Levy MA. Regressing thin cutaneous malignant melanomas (<1.0 mm) are associated with angiogenesis. Am J Pathol 1993:143:99-104.
16. Nasser I, Tahan S. Angiogenesis in melanocytic lesions and its relationship to tumor progression. Mod Pathol 1993;6:abstr 35.
17. Fallowfield MD, Cook MG. The vascularity of primary cutaneous melanoma. J Pathol 1991:164:241-4.
18. Weidner N, Folkman J, Pozza F., Bevilacqua P, Allred EN, Moore DH, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma [see comment citations in Medline]. J Natl Cancer Inst 1992;84:1875-87.
19. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992;340:1120-4.
20. Visscher DW, Smilanetz S, Drozdowicz S, Wykes SM. Prognostic significance of image morphometric microvessel enumeration in breast carcinoma. Anal Quant Cytol Histol 1993; 15:88-92.
21. Sneige N, Singletary E, Sahin A, El-Naggar A. Multiparameter analysis of potential prognostic factors in node negative breast cancer patients. Mod Pathol 1992;5:abstr 18.
22. Sahin AA, Sneige N, Ordonez NG, Singletary E, Ayala AG. Tumor angiogenesis detected by Ule.x Europaeus agglutinin 1 lectin (UEA-1) and factor VIII immunostaining in node-negative breast carcinoma (NNBC) treated by mastectomy: prediction of tumor recurrences. Mod Pathol 1993;6:abstr 19.
23. Toi M, Kashitani J, Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 1993;55:371-4.
24. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 1992;340:145-6.
25. Wakui S, Furusato M, Itoh T, Sasaki H, Akiyama A, Kinoshita I, et al. Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol 1992; 168:257-62.
26. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-9.
27. Brawer MK, Deering RE, Brown M, Preston SD, Bigler SA. Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer1994;73:678-87.
28. Van Hoef ME, Knox WF, Dhesi SS, Howell A, Schor AM. Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. EurJ Cancer 1993;29A:1141-5.
29. Hall NR, Fish DE, Hunt N, Goldin RD, Guillou PJ, Monson JR. Is the relationship between angiogenesis and metastasis in breast cancer real?Surg Oncol 1992;1:223-9.
30. Bergkvist A, Ljungqvist A, Moberger G. Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 1965;130:371-8.
31. Hermanek P, Sobin LH, editors. TNM classification of malignant tumours. 4th ed. New York: Springer-Verlag, 1987:133-4.
32. Shi SR, Key ME, Kalra K. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991;39:741-8.
33. Bochner BH, Nichols PW, Groshen S, Skinner DG, Cote RJ. Differential endothelial staining of the human hematopoietic progenitor cell antigen (CD34) and factor VIII antigen: utility in microvessel (angiogenesis) identification in bladder cancer. Lab Invest 1995;72:abstr416.
34. Weidner N, Semple JP, Welch W, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
35. Miller RG. Survival analysis. New York: John Wiley & Sons, 1981.
36. Gaynor JJ, Feure EJ, Tan CC, Wu DH, Little CR, Straus DJ, et al. On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. J Am Stat Assoc 1993;88:400-9.
37. Jaeger TM, Weidner N, Chew K, Moore DH, Kerschmann RL, Waldman FM, et al. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J Urol 1995;154:69-71.
38. Dickinson AJ, Fox SB, Persad RA, Hollyer J, Sibley GN, Harris AL. Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Br J Urol 1994;74:762-6.
39. Deen S, Ball RY. Basement membrane and extracellular interstitial matrix components in bladder neoplasia-evidence of angiogenesis. Histopathol-ogy 1994;25:475-81.
40. Joseph A, Weiss GH, Jin L, Fuchs A, Chowdhury S, O’Shaugnessy P, et al. Expression of scatter factor in human bladder carcinoma. J Natl Cancer Inst 1995;87:372-7.
41. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 1993;143:1255-62.
42. Craft PS, Harris AL. Clinical prognostic significance of tumour angiogenesis. Ann Oncol 1994;5:305-11.
43. Folkman J. What is the evidence that tumors are angiogenesis dependent? [editorial] J Natl Cancer Inst 1990;82:4-6.
44. Nagy JA, Brown LF, Senger DR, Lanir N, Van de Water L, Dvorak AM, et al. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 1989;948:305-26.
45. Moscatelli D, Gross J, Rifkin D. Angiogenic factors stimulate plasminogen activator and collagenase production by capillary endothelial cells. J Cell Biol 1981;91:abstr 201.
46. Liotta LA, Kleinerman J, Saidel GM. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 1974;34:997-1004.
47. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-a. Nature 1987;329:630-2.
48. Folkman J, Klagsbum M, Sasse J, Wadzinski M, Ingber D, Voldavsky I. A heparin-binding angiogenic protein-basic fibroblast growth factor-is stored within the basement membrane. Am J Pathol 1988;130:393-400.
49. Rastinejad F, Polverini PJ, Bouck NP. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 1989;56:345-55.
50. Dameron KM, Volpert OV, Tainsky MA, Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science1994;265:1582-4.
51. Skinner DG, Daniels JR, Russell CA, Lieskovsky G, Boyd SD, Nichols P. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 1991; 145:459-64.
52. Stockle M, Meyenburg W, Wellek S, Voges G, Gertenbach U, Thuroff JW, et al. Advanced bladder cancer (stages pT3b, pT4a, pNl and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. J Urol1992; 148(2 Pt l):302-6.